Entera Bio Ltd. (ENTX)
1.60
-0.14
(-8.05%)
USD |
NASDAQ |
Jan 09, 16:00
1.615
+0.02
(+0.94%)
After-Hours: 20:00
Entera Bio EPS Diluted (Quarterly): -0.068 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.20M |
| Total Expenses (Quarterly) | 3.20M |
| Enterprise Value | 56.98M |
| Earnings Yield | -15.29% |
| Normalized Earnings Yield | -15.29 |